| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| INDIRECT ACCOUNTING FEES | 515 | 510 |
| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| BETTERMENT | 2024-04 | PURCHASE | 2024-05 | 1,497 | 1,506 | -9 | ||||
| BETTERMENT | 2022-10 | PURCHASE | 2024-05 | 35,629 | 35,777 | -148 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| EXPENSES | ||||
| BANK CHARGES | 42 | 42 | ||
| FDA FOR PRODUCT APPROVAL | 36,267 | 36,267 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| US TREASURY | 39 | |||
| CO FILING FEES | 35 | 35 |